These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 33070144)

  • 1. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
    Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA
    Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
    Muluneh B; Dean A; Armistead P; Khan T
    J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
    J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
    Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
    Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
    Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A
    J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of acyclovir-resistant herpes simplex virus.
    Chilukuri S; Rosen T
    Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
    Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
    Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
    Chen Y; Scieux C; Garrait V; Socié G; Rocha V; Molina JM; Thouvenot D; Morfin F; Hocqueloux L; Garderet L; Espérou H; Sélimi F; Devergie A; Leleu G; Aymard M; Morinet F; Gluckman E; Ribaud P
    Clin Infect Dis; 2000 Oct; 31(4):927-35. PubMed ID: 11049772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
    LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB
    Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489
    [No Abstract]   [Full Text] [Related]  

  • 13. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.
    Akahoshi Y; Kanda J; Ohno A; Komiya Y; Gomyo A; Hayakawa J; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Shiraki K; Kanda Y
    J Infect Chemother; 2017 Jul; 23(7):485-487. PubMed ID: 28262533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
    Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
    Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of next-generation sequencing to detect acyclovir-resistant herpes simplex virus type 1 variants at low frequency in thymidine kinase gene of the isolates recovered from patients with hematopoietic stem cell transplantation.
    Fujii H; Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Yamada S; Omura N; Inagaki T; Shibamura M; Harada S; Taniguchi S; Saijo M
    J Virol Methods; 2018 Jan; 251():123-128. PubMed ID: 29074089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Intrathecal Acyclovir Resistant Virus in Herpes Simplex Encephalitis Patients.
    Mitterreiter JG; Titulaer MJ; van Nierop GP; van Kampen JJ; Aron GI; Osterhaus AD; Verjans GM; Ouwendijk WJ
    PLoS One; 2016; 11(5):e0155531. PubMed ID: 27171421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
    Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
    Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.